Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

Drug development is a long and complex process that involves many steps, from discovery to clinical trials. Learn about the different stages of drug development, the challenges involved ...

The Essential3 program for ulixacaltamide in treating essential tremor is on track for interim analysis in Q1 2025, with an NDA ... a development candidate for each of its early stage ASO ...